India’s top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR. A vaccine is vital for India as the country battles a severe TB crisis.
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
